Leap Therapeutics soars 368% after pivoting to ZCash crypto treasury
Leap Therapeutics (LPTX) has made waves in the crypto news today, closing 368% higher on Nov. 12 after announcing a new crypto treasury strategy focused on ZCash (ZEC). The company, set to rebrand as Cypherpunk Technologies and trade under the new ticker CYPH from Nov. 13, has secured nearly $59 million in funding and deployed a significant portion to acquire ZCash tokens.
LPTX's bold move comes amidst a surge in ZCash's momentum, which has soared over 1,400% in 2025. Known as the 'encrypted Bitcoin', ZCash attracts investors with its superior safety features. However, investing in LPTX carries risks, primarily due to ZCash's volatility and potential regulatory issues surrounding privacy coins.
Major exchanges have begun delisting privacy assets, and Arthur Hayes warned ZEC holders to withdraw from centralized exchanges. Despite these challenges, LPTX's strategy positions it to benefit from ZCash's growth. The company's stock price is around 9x its mid-August level, reflecting the positive momentum.
Wall Street analysts have a 'Hold' consensus rating on LPTX shares, with a mean target of about $1.25. This suggests a potential downside of more than 35%. However, the recent strong increase of around +368% to +424% indicates significant positive momentum or analyst interest. LPTX shares may attract previously sidelined crypto-focused investors, driving them higher in 2026.
Leap Therapeutics' rebranding as Cypherpunk Technologies and its focus on ZCash present both opportunities and risks. While the company's strategy could capitalize on ZCash's growth, investors must be aware of the volatility and regulatory challenges associated with privacy coins. As LPTX begins trading under the new ticker CYPH, investors will closely watch its progress in the dynamic crypto news market.
